Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Assets: 2015-2024

Historic Current Assets for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $320.4 million.

  • Wave Life Sciences' Current Assets fell 33.60% to $215.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.5 million, marking a year-over-year decrease of 33.60%. This contributed to the annual value of $320.4 million for FY2024, which is 36.12% up from last year.
  • As of FY2024, Wave Life Sciences' Current Assets stood at $320.4 million, which was up 36.12% from $235.4 million recorded in FY2023.
  • Wave Life Sciences' Current Assets' 5-year high stood at $320.4 million during FY2024, with a 5-year trough of $98.5 million in FY2022.
  • Over the past 3 years, Wave Life Sciences' median Current Assets value was $235.4 million (recorded in 2023), while the average stood at $218.1 million.
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 39.39% in 2022, then spiked by 138.87% in 2023.
  • Wave Life Sciences' Current Assets (Yearly) stood at $230.0 million in 2020, then dropped by 29.33% to $162.6 million in 2021, then plummeted by 39.39% to $98.5 million in 2022, then spiked by 138.87% to $235.4 million in 2023, then skyrocketed by 36.12% to $320.4 million in 2024.